Protagonist Therapeutics
(NASDAQ:PTGX)
$28.93
0.45[1.58%]
At close: Mar 28
$28.93
0[0.00%]
After Hours: 4:00PM EDT
50%
Overview Rating
Speculative
Technicals Analysis
100
0100
Financials Analysis
20
0100

Protagonist Therapeutics Stock (NASDAQ:PTGX), Quotes and News Summary

Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.

Open$28.420
Close$28.930
Volume / Avg.653.366K / 728.652K
Day Range28.130 - 29.270
52 Wk Range13.720 - 33.340
Market Cap$1.686B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
52
Short Interest
4.83%
Days to Cover2.65
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Oct 23
0
0
0
0
Nov 23
2
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Protagonist Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary tech...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PTGX
IMNM

FAQ

Q

How do I buy Protagonist Therapeutics (PTGX) stock?

A

You can purchase shares of Protagonist Therapeutics (NASDAQ: PTGX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Protagonist Therapeutics's (PTGX) competitors?

Q

What is the target price for Protagonist Therapeutics (PTGX) stock?

A

The latest price target for Protagonist Therapeutics (NASDAQ: PTGX) was reported by HC Wainwright & Co. on Monday, March 11, 2024. The analyst firm set a price target for 38.00 expecting PTGX to rise to within 12 months (a possible 31.35% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Protagonist Therapeutics (PTGX)?

A

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $28.93 last updated March 28, 2024 at 4:00 PM EDT.

Q

Does Protagonist Therapeutics (PTGX) pay a dividend?

A

There are no upcoming dividends for Protagonist Therapeutics.

Q

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

A

Protagonist Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Protagonist Therapeutics (PTGX) going to split?

A

There is no upcoming split for Protagonist Therapeutics.

Q

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

A

Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch